Office of Commercialization and Economic Development
Office of Technology Commercialization

Monoclonal Antibody: AMPK Alpha

Technology #07-0101

This monoclonal antibody recognizes AMPK catalytic subunits alpha 1 and alpha 2 from diverse species spanning humans to fruit flies. Possibly a useful biomarker for studies of Type 2 diabetes and Cancer or as a diagnostic tool for evaluating AMPK activity in lysates by immunoprecipitation followed by kinase assays.

If you are an academic institution or nonprofit organization interested in this research tool for noncommercial purposes, please contact the researcher directly to inquire about availability.

Related Publications: